SCHEMBL1616604

SCHEMBL1616604

N#Cc1cccc2nc(N[C@@H]3CCc4ccccc43)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.43
HDAC6 Q9UBN7 1/20 0.42
KCNN3 Q9UGI6 1/20 0.42
FADS1 O60427 1/20 0.41
PDPK1 O15530 1/20 0.40
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
PFKFB3 Q16875 3/20 0.38
EGFR P00533 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
BCHE P06276 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
ACHE P22303 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR6 P50406 1/20 0.38
PARP1 P09874 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2245619 0.84 GBA1 (0.47) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1615946 0.82 GBA1 (0.48) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1615945 0.82 GBA1 (0.48) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1616343 0.82 GBA1 (0.46) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1616344 0.82 GBA1 (0.46) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1616241 0.81 GBA1 (0.50) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1616249 0.81 GBA1 (0.50) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL1615788 0.80 GBA1 (0.44) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL3844986 0.80 PDPK1 (0.47) GBA1HDAC6KCNN3FADS1PDPK1
SCHEMBL2241645 0.79 PFKFB3 (0.54) GBA1FADS1PDPK1PFKFB3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994324-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US disclosed
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US disclosed
EP-2262773-A1 2-AMINOQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP disclosed
WO-2009109491-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US disclosed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US disclosed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES HTR5A, HTR2C, HTR2B GBA1 1247/4885HDAC6 944/4885KCNN3 1905/4885
US-20080146567-A1 QUINOLINES HTR5A, HTR2B, HTR2C GBA1 662/4885HDAC6 852/4885KCNN3 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.